A detailed history of Citigroup Inc transactions in Tactile Systems Technology Inc stock. As of the latest transaction made, Citigroup Inc holds 96,347 shares of TCMD stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
96,347
Previous 5,407 1681.89%
Holding current value
$1.67 Million
Previous $64,000 2098.44%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$11.29 - $14.61 $1.03 Million - $1.33 Million
90,940 Added 1681.89%
96,347 $1.41 Million
Q2 2024

Aug 12, 2024

BUY
$11.13 - $15.8 $15,426 - $21,898
1,386 Added 34.47%
5,407 $64,000
Q1 2024

May 10, 2024

SELL
$13.63 - $16.75 $50,826 - $62,460
-3,729 Reduced 48.12%
4,021 $65,000
Q4 2023

Feb 09, 2024

BUY
$9.95 - $14.73 $56,515 - $83,666
5,680 Added 274.4%
7,750 $110,000
Q3 2023

Nov 09, 2023

SELL
$12.95 - $25.63 $63,843 - $126,355
-4,930 Reduced 70.43%
2,070 $29,000
Q2 2023

Aug 10, 2023

BUY
$16.36 - $24.93 $113,358 - $172,739
6,929 Added 9759.15%
7,000 $174,000
Q1 2023

May 11, 2023

SELL
$11.85 - $16.7 $1,220 - $1,720
-103 Reduced 59.2%
71 $1,000
Q4 2022

Feb 09, 2023

SELL
$6.71 - $11.89 $15,721 - $27,858
-2,343 Reduced 93.09%
174 $1,000
Q3 2022

Nov 10, 2022

SELL
$6.56 - $10.75 $5,917 - $9,696
-902 Reduced 26.38%
2,517 $20,000
Q2 2022

Aug 10, 2022

SELL
$6.55 - $21.5 $104,007 - $341,398
-15,879 Reduced 82.28%
3,419 $25,000
Q1 2022

May 12, 2022

BUY
$13.68 - $20.69 $32,708 - $49,469
2,391 Added 14.14%
19,298 $389,000
Q4 2021

Feb 10, 2022

SELL
$18.98 - $45.93 $46,538 - $112,620
-2,452 Reduced 12.67%
16,907 $322,000
Q3 2021

Nov 10, 2021

BUY
$39.89 - $52.93 $772,230 - $1.02 Million
19,359 New
19,359 $860,000

Others Institutions Holding TCMD

About TACTILE SYSTEMS TECHNOLOGY INC


  • Ticker TCMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,132,100
  • Market Cap $349M
  • Description
  • Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for th...
More about TCMD
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.